My bet is that is is something to do with advancing the case towards FDA approval for AARDs. Joel is always looking a step ahead and honestly is one of the most under rated players on the ASX. Everyone is always talking about the BOD. Joel is the master mind in my view.
IHL Price at posting:
22.0¢ Sentiment: Buy Disclosure: Held
